ADCC-Enhanced anti-Claudin 1 biobetter
ADCC-Enhanced anti-Claudin 1 (6F6C3) is a non-fucosylated therapeutic biobetter antibody engineered by Creative Biolabs' Afuco™ technology platform. By reducing the fucosylation of the Fc region, the ADCC-enhanced antibody shows an increased binding affinity for the FcyR receptor on immune effector cells.